The news: A federal judge in Massachusetts has temporarily halted HHS Secretary Robert F. Kennedy Jr.’s aggressive efforts to rewrite US vaccine policy, including a rule to overhaul childhood vaccine schedules.

Digging into the details: A preliminary injunction has reversed, for now, recent CDC vaccine guidelines following a lawsuit by the American Academy of Pediatrics and other medical associations. Judge Brian Murphy’s ruling temporarily blocks several ACIP-recommended shifts, including reducing the number of routine diseases that kids are immunized against from 17 to 11, and changes to infant Hepatitis B protocols. The ruling also suspends new ACIP appointments. It remains unclear if the revised COVID-19 recommendations for pregnant women and children will be reinstated.

Why it matters: Amid shifting vaccine guidance, several states and medical associations issued their own recommendations for healthcare providers and institutions that contradict the government’s changes. This has essentially created two sets of guidelines that doctors, pharmacists, and patients have been left to navigate.

The temporary court ruling may add further confusion, but it also strengthens the position of medical groups and doctors opposing the government’s changes—many of whom consumers see as the most trusted source of health information.

• 77% of consumers say they have confidence in public health guidance from the AAP and 73% from the AMA, according to a March 2026 Annenberg study.
• Trust falls to 60% for the CDC, 43% for federal health agency leaders, and 38% for Kennedy himself.
• Consumers are two to four times more likely to trust the AMA or AAP over the CDC if the two sides disagree on vaccine safety and issue conflicting recommendations.

Implications for healthcare professionals: Clashes among prominent authorities over vaccine policy have pushed many people to see themselves as “in the middle,” prompting them to seek more information, especially when deciding about children’s shots. For now, medical groups, doctors, and pharmacists gain a major “win,” strengthening their leverage with uncertain parents and patients as government vaccine credibility wanes—reinforcing long-established guidance as the trusted source of truth.